Double maintains 1 strategies that include NRIX - Nurix Therapeutics, Inc.
Current Value
$12.421 Year Return
Current Value
$12.421 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SHY | 0.08% | $23.54B | 0.15% |
| STIP | 0.14% | $12.68B | 0.03% |
| GSST | -0.19% | $920.88M | 0.16% |
| CGMU | 0.22% | $3.38B | 0.27% |
| CMF | 0.26% | $3.50B | 0.08% |
| TYA | -0.42% | $147.35M | 0.15% |
| LDUR | -0.42% | $922.12M | 0.5% |
| IBTJ | -0.44% | $686.15M | 0.07% |
| ICSH | 0.49% | $5.96B | 0.08% |
| IBTK | -0.51% | $445.94M | 0.07% |
| BSV | 0.57% | $37.89B | 0.03% |
| UNG | 0.62% | $375.27M | 1.06% |
| BWX | -0.64% | $1.53B | 0.35% |
| SMB | -0.78% | $276.62M | 0.07% |
| IBTL | 0.78% | $381.26M | 0.07% |
| PSQA | 0.82% | $36.49M | 0.2% |
| IBMN | -0.83% | $445.23M | 0.18% |
| HYMB | -0.84% | $2.62B | 0.35% |
| TDTT | -0.85% | $2.63B | 0.18% |
| IBTM | 0.86% | $316.60M | 0.07% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | 0.01% | $89.25B | +24.22% | 0.40% |
| LTM | -0.18% | $12.85B | -95.43% | 2.39% |
| MNOV | -0.22% | $62.29M | -8.63% | 0.00% |
| KR | 0.23% | $46.75B | +34.05% | 1.81% |
| MDLZ | 0.26% | $86.95B | +2.80% | 2.82% |
| CCRN | 0.30% | $408.48M | -8.25% | 0.00% |
| HSY | -0.56% | $33.36B | -11.86% | 3.35% |
| AEP | -0.63% | $56.65B | +16.73% | 3.49% |
| DUK | -0.74% | $91.85B | +13.12% | 3.57% |
| EXC | -0.76% | $44.05B | +23.53% | 3.60% |
| AQB | 0.86% | $3.04M | -56.34% | 0.00% |
| BCE | 0.88% | $22.18B | -25.44% | 10.20% |
| CREG | 0.95% | $5.91M | -76.05% | 0.00% |
| HUSA | 0.98% | $20.99M | -8.33% | 0.00% |
| BTCT | 1.04% | $28.19M | +79.43% | 0.00% |
| K | 1.11% | $27.64B | +40.17% | 2.86% |
| IMNN | -1.15% | $13.21M | -54.55% | 0.00% |
| TU | 1.32% | $25.21B | +7.34% | 6.98% |
| DFDV | 1.37% | $363.21M | +2,422.23% | 0.00% |
| GORV | 1.43% | $26.23M | -91.97% | 0.00% |
Yahoo
Health care stocks were mixed premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) wa
Yahoo
US equity futures were nearly flat before Thursday's opening bell following the release of the weekl
Yahoo
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.02% and the actively tra
Yahoo
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license fee as Sanofi extends STAT6 collaboration to target type 2 inflammatory diseases Announced FDA clearance of IND application for novel IRAK4 degrader GS-6791/NX-0479, enabling collaboration partner Gilead to initiate Phase 1 trial Well capitalize
Finnhub
SAN FRANCISCO - Nurix Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, announced...
Yahoo
Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLLSAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to bexobrut
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -40.48% | $184.73M | 0.85% |
| BTAL | -39.86% | $315.93M | 1.43% |
| TAIL | -36.85% | $94.86M | 0.59% |
| IVOL | -17.66% | $342.69M | 1.02% |
| TBLL | -12.30% | $2.12B | 0.08% |
| ULST | -11.17% | $592.38M | 0.2% |
| XONE | -10.99% | $628.85M | 0.03% |
| FXY | -10.03% | $802.69M | 0.4% |
| TPMN | -9.95% | $31.06M | 0.65% |
| JMST | -9.52% | $4.09B | 0.18% |
| SPTS | -8.93% | $5.77B | 0.03% |
| XHLF | -8.68% | $1.73B | 0.03% |
| TFLO | -8.49% | $6.74B | 0.15% |
| UTWO | -8.07% | $376.33M | 0.15% |
| DFNM | -7.85% | $1.58B | 0.17% |
| SCHO | -7.54% | $10.98B | 0.03% |
| CLIP | -5.89% | $1.55B | 0.07% |
| SHYM | -5.87% | $355.86M | 0.35% |
| VGSH | -5.66% | $22.68B | 0.03% |
| GBIL | -5.56% | $6.36B | 0.12% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 67.08% | $4.81B | 0.35% |
| GNOM | 62.27% | $46.47M | 0.5% |
| IBB | 61.03% | $5.37B | 0.45% |
| PTH | 58.85% | $96.25M | 0.6% |
| ARKG | 58.67% | $1.03B | 0.75% |
| XPH | 58.44% | $150.58M | 0.35% |
| PBE | 58.09% | $226.91M | 0.58% |
| IWC | 54.25% | $840.86M | 0.6% |
| PINK | 53.87% | $130.30M | 0.5% |
| IWO | 53.67% | $11.77B | 0.24% |
| FBT | 53.55% | $1.02B | 0.54% |
| IWM | 51.81% | $65.64B | 0.19% |
| VTWO | 51.81% | $12.65B | 0.07% |
| BBH | 51.10% | $339.54M | 0.35% |
| RDTE | 50.85% | $139.04M | 0.97% |
| SCHA | 50.36% | $17.61B | 0.04% |
| ISCG | 50.28% | $688.57M | 0.06% |
| KJUL | 50.17% | $159.39M | 0.79% |
| KJAN | 49.90% | $279.50M | 0.79% |
| GSSC | 49.41% | $591.16M | 0.2% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KYMR | 67.22% | $3.17B | +15.92% | 0.00% |
| DNLI | 61.73% | $2.23B | -33.52% | 0.00% |
| IDYA | 58.69% | $2.00B | -42.45% | 0.00% |
| RNA | 56.81% | $3.79B | -28.98% | 0.00% |
| BEAM | 55.67% | $2.22B | -14.88% | 0.00% |
| OCUL | 55.57% | $1.77B | +45.79% | 0.00% |
| CRNX | 54.96% | $3.00B | -39.42% | 0.00% |
| XENE | 52.76% | $2.53B | -19.91% | 0.00% |
| SYRE | 51.72% | $963.24M | -43.26% | 0.00% |
| RVMD | 51.46% | $7.17B | -11.19% | 0.00% |
| IMNM | 50.75% | $778.76M | -31.05% | 0.00% |
| ZYME | 50.68% | $959.66M | +38.40% | 0.00% |
| STOK | 50.59% | $657.35M | -14.18% | 0.00% |
| DYN | 50.47% | $1.25B | -79.03% | 0.00% |
| CGON | 50.10% | $2.07B | -21.33% | 0.00% |
| ATXS | 50.09% | $376.42M | -40.71% | 0.00% |
| SNDX | 49.38% | $844.99M | -58.21% | 0.00% |
| XNCR | 48.86% | $660.47M | -52.14% | 0.00% |
| APGE | 48.79% | $2.30B | -16.02% | 0.00% |
| RGNX | 48.60% | $456.52M | -28.72% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -17.02% | $24.55B | +38.09% | 1.08% |
| CME | -11.79% | $99.17B | +44.04% | 1.75% |
| T | -8.85% | $198.74B | +46.45% | 5.06% |
| VSTA | -6.53% | $325.62M | +30.97% | 0.00% |
| VZ | -6.49% | $177.21B | +1.77% | 8.05% |
| ED | -6.17% | $36.42B | +10.51% | 3.36% |
| ZCMD | -6.02% | $28.54M | -8.87% | 0.00% |
| VSA | -5.42% | $8.59M | -17.17% | 0.00% |
| MO | -5.37% | $98.62B | +24.36% | 7.00% |
| KMB | -5.16% | $43.78B | -6.43% | 3.77% |
| AMT | -4.72% | $103.46B | +6.67% | 3.01% |
| NOC | -4.32% | $73.96B | +18.95% | 1.66% |
| CNC | -3.83% | $16.18B | -51.64% | 0.00% |
| MKTX | -3.55% | $8.21B | +2.36% | 1.37% |
| NEUE | -3.51% | $60.71M | +34.39% | 0.00% |
| AIFU | -3.49% | $17.40M | +87.81% | 0.00% |
| AWK | -3.27% | $27.82B | +4.74% | 2.18% |
| VHC | -3.16% | $69.05M | +176.10% | 0.00% |
| AGRO | -2.74% | $913.94M | -7.96% | 3.83% |
| TEF | -2.69% | $29.35B | +18.72% | 6.32% |
